Susceptibility Testing of Medically Important Parasites.

Area of Science:

• Parasitology
• Drug Discovery
• Antimicrobial Resistance

Background:

• Neglected tropical diseases (NTDs) require new antiparasitic agents due to rising drug resistance.
• Standardized in vitro parasite culture and susceptibility testing are essential for drug development.
• There is a need to correlate laboratory findings with clinical treatment outcomes, particularly for malaria.

Purpose of the Study:

• To review current methodologies for evaluating antiparasitic drug efficacy.
• To highlight the importance of in vitro screening in drug discovery for parasitic infections.
• To discuss the necessity of laboratory methods that correlate with clinical outcomes.

Main Methods:

• Review of state-of-the-art in vitro screening techniques for antiparasitic agents.
• Analysis of parasite culture methodologies.
• Examination of methods for correlating in vitro susceptibility data with clinical outcomes.

Main Results:

• The review catalogs various in vitro methods for assessing drug effects on human parasites.
• It addresses the complexities of parasite life cycles compared to bacteria in susceptibility testing.
• The need for validated laboratory methods linking in vitro results to patient treatment success is emphasized.

Conclusions:

• Effective drug discovery for NTDs relies on robust in vitro screening and culture methods.
• Developing standardized laboratory tests that predict clinical efficacy is critical.
• Bridging the gap between in vitro drug evaluation and real-world treatment outcomes is a key challenge.